The Secret of Brain Aging in Large Dogs: Why They Live Shorter but Their Brains Stay Young

If you've ever wondered why a German Shepherd lives 7-8 years while a Chihuahua lives 17, you should know about the interesting paradox that scientists have been trying to understand for years. Large dogs die young. That's known. But new studies reveal a mystery: The brain of a large dog ages at the same rate as that of a small dog. The reason for this gap may reveal something profound about aging in general. A new experiment called SIGNAL from the University of Arizona is set to investigate the hormone IGF-1 as the explanatory factor.

The Paradox of Size and Age

In mammals in general, there is a clear rule: Larger animals live longer. An elephant lives 70 years. A mouse lives 2-3 years. It makes sense: a large body = slow metabolism = less cell damage = longer life.

But in dogs, it's the opposite! And it's not an inconsistency. It's a phenomenon specific to the species. All these breeds are biologically the same species, only bred to different sizes through selective breeding. So why do large dogs die young?

A leading theory: IGF-1 (Insulin-like Growth Factor 1). This is a hormone that promotes growth. Large dogs have high levels of it. This allows them to grow to enormous sizes. But in the long term, high IGF-1 is linked to cancer, heart disease, and shortened lifespan.

The Surprising Discovery: The Brain Doesn't Age Faster

Associate Professor Evan MacLean, an associate professor of veterinary medicine at the University of Arizona, studies the connection between growth hormones and cognition in dogs. Concurrently, a large-scale study by the Dog Aging Project (Hargrave and colleagues, published in GeroScience in 2025) examined the issue on a massive sample. The researchers developed two short-term spatial memory tests administered by volunteer dog owners and tested approximately 6,753 dogs of all sizes. Each dog faced cognitive tasks such as:

• Working memory (where did I hide the treat 30 seconds ago)
• Problem-solving (how to get the treat behind a barrier)
• Self-control (waiting for a command instead of jumping)
• Social communication (responding to human cues)

Logic suggests that large dogs, with much shorter lifespans, would show accelerated cognitive decline. But the findings showed otherwise: the relationship between age and cognitive function was very similar in both small and large dogs. Cognitive decline begins in mid-life and progresses at a similar rate, regardless of body size. MacLean explains the logic behind the opposite expectation:

"Based on the different lifespans, we would expect large dogs like German Shepherds to show signs of dementia around age 8, while small dogs like Chihuahuas would develop them later, somewhere in their teens. But that's not what we find." (Associate Professor Evan MacLean)

The implication, according to MacLean, is interesting: it's possible that large dogs simply die before they have a chance to develop impaired cognitive function. The fact that there is no evidence of accelerated brain aging in them raises the possibility that their large size actually provides them with some protective advantage for the brain.

The SIGNAL Experiment: What It Will Test

To deeply investigate what drives this connection, MacLean is launching SIGNAL (Study of IGF-1, Neurocognitive Aging and Longevity), a new study supported by the AKC Canine Health Foundation. It's important to clarify: this is a study that has not yet been conducted, and it is intentionally small and precise. It will include 75 medium-sized dogs from the local community (15-25 kg, about 33-55 pounds), aged 10-13, thus neutralizing the size variable. The study will examine:

1. Blood levels of IGF-1 in the dogs over time
2. Individual cognitive tests, adapted over about two years
3. The connection between the two: Do specific IGF-1 levels predict brain aging, independent of size?

And here's the big surprise regarding the direction. Contrary to the intuition that "high IGF-1 is always bad," MacLean's hypothesis for the brain is the opposite: he predicts that dogs with higher IGF-1 levels will perform better on cognitive tasks. The reason: IGF-1 is not just a physical growth hormone; it also affects the brain. It may support neuron repair after injury, encourage neural growth (neurogenesis), and help clear amyloid deposits. So, the same hormone may shorten life on one hand (cancer) but protect the brain on the other.

Why Is This Interesting for Humans?

IGF-1 also exists in humans, and the picture for us is equally complex and fascinating:

1. People with low levels of IGF-1 tend to live longer: Super-centenarians (over age 100) tend to carry genetic mutations in the IGF-1 receptor that weaken its signal
2. But too-low levels harm the brain: Very low levels of IGF-1 are linked to dementia and cognitive decline
3. The catch: balance is needed. Both too high (cancer risk and shortened lifespan) and too low (brain risk) are problematic. There is likely an optimal range in the shape of a U-curve

This is what scientists call antagonistic pleiotropy: genes that help you in youth (e.g., physical growth) may harm you in old age (cancer, accelerated aging). IGF-1 is a classic example, and this is precisely the dilemma: what extends the body's life may harm the brain, and vice versa. This is also what makes the dog story so relevant; the hormone is not universally "good" or "bad," but tissue-dependent and age-dependent.

Differences Between Dogs and Humans

Although dogs are useful as a model, there are important differences to keep in mind:

• Lifespan: Dogs live 7-17 years, humans 70-90. Hormones operate at different rates over time
• Brain size: The human brain has about 86 billion neurons total (of which about 16 billion are in the cortex). The dog brain has about 2 billion neurons total (about 530 million in the cortex). It's important to compare apples to apples: whole brain to whole brain, or cortex to cortex
• Selective breeding: Dog sizes were determined by humans, while humans evolved naturally

Nevertheless, the connection between IGF-1 and aging is a fundamental mechanism that crosses species, and this is precisely why dogs, which share our environment and diet, are an excellent model for studying aging, even if SIGNAL itself is still ahead of us.

Experimental Treatment: GHRH for Old Dogs

In a separate but related research direction, a study published in Frontiers in Veterinary Science in 2025 (Ryu and colleagues) examined treatment in healthy old dogs using GHRH (Growth Hormone Releasing Hormone). The treatment was administered via plasmid DNA and injection with electroporation. The treated dogs showed:

• Improved well-being and activity as reported by owners
• Increased limb circumference, as an indirect measure of muscle mass
• Signs of improved immune function
• Good tolerance to treatment without serious side effects

This is a deliberately opposite approach: increasing the growth hormone axis specifically in old age, when its levels naturally drop, based on the assumption that the increase restores some function. The contrast between this approach (increase) and the evidence that low IGF-1 levels extend lifespan (decrease) again illustrates the balance dilemma.

The Big Question: Balance

So, high IGF-1 throughout life shortens lifespan, but too-low GH/IGF-1 axis harms the brain and muscle. What is the optimum? This is precisely what SIGNAL and additional studies are trying to solve.

The leading hypothesis: The desired balance may change with age, sufficient levels in youth (for normal growth and brain health) versus moderate restraint in old age (for longevity), but without dropping so low that it harms cognition. The exact optimal range is still unknown, and it may differ for the body and the brain.

What Can You Do?

It's important to qualify: for healthy humans, there is no blanket recommendation to "lower IGF-1"; this is an active research arena, not a prescription. However, a balanced lifestyle that affects this axis includes:

• Less excess animal protein: A Mediterranean diet emphasizing fish and plant protein has been linked to a moderate decrease in IGF-1 (around 11% in a controlled study), and a vegan diet to a similar decrease (about 9-13%)
• Avoiding excessive red meat consumption: Linked to high IGF-1 and health risk
• Intermittent fasting: May lower IGF-1 for periods, which is being studied as beneficial
• Balance in physical activity: Resistance training temporarily raises IGF-1, and moderate general activity has less effect. Both types are healthy; context matters
• In very old and frail individuals: This may be a case where supporting the GH/IGF-1 axis is warranted, but only under medical supervision

The bottom line: The relationship between IGF-1 and health is one of balance, not "as little as possible", especially when it comes to the brain.

The Bottom Line

Dogs offer us an interesting insight: a large body does not necessarily mean a faster-aging brain. In fact, separate mechanisms may control the rate of body aging and the rate of brain aging. If we understand them, we might be able to treat each one separately. IGF-1 appears to be a central candidate in this equation, but the surprise is the direction: for the brain, it may be that sufficient levels protect, not low ones. The SIGNAL study, still ahead of us, is designed precisely to test this.